Aims To determine clinical outcomes and explore prognostic factors related to ulcer healing in people with a clinically infected diabetic foot ulcer.
Introduction
One of the most common and serious complications of diabetes mellitus is the development of a foot ulcer, which occurs in up to a quarter of patients over their lifetime [1] . These diabetic foot ulcers, which primarily result from peripheral nerve damage and arterial disease, are associated with substantial morbidity, often including hospitalization and lower extremity amputation, as well as increased mortality [2] . These complications also lead to substantial healthcare costs and loss of productivity [3] [4] [5] . Over half of diabetic foot ulcers are clinically infected at presentation [6] , and these infected diabetic foot ulcers are especially associated with poor outcomes [7] [8] [9] [10] [11] [12] .
Understanding factors associated with diabetic foot ulcer healing may better inform prevention and management strategies. Prospective data on clinical outcomes of infected diabetic foot ulcer are scarce. Two large inception cohort studies [5, [13] [14] [15] assessed factors associated with diabetic foot ulcer healing, but neither specifically recruited people with infected ulcers and both were limited to specialist centres. Ince et al. [13] and Jeffcoate et al. [14] found that among people attending one diabetic foot ulcer clinic for whom there was a 1-year follow-up, there was a relationship between time to healing and ulcer area, peripheral arterial disease, ulcer site and diabetes duration. The European Study Group on Diabetes and the Lower Extremity (Eurodiale) study [5, 15] in people with a new diabetic foot ulcer presenting to one of 14 diabetic foot ulcer clinics, and for whom there was a 1-year follow-up, identified independent predictors of delayed healing as: older age;, male sex; larger ulcer size; heart failure; inability to stand or walk without help; end-stage renal disease; peripheral neuropathy; and peripheral arterial disease [15] . Current guidelines for the management of infected diabetic foot ulcer [16] [17] [18] [19] [20] highlight the importance of prevention, early diagnosis and appropriate therapy delivered by a multidisciplinary team.
Our group recently completed a large, multicentre, crosssectional study that compared culture results from swab and tissue specimens concurrently obtained from people with a diabetic foot ulcer with suspected infection (the Concordance in Diabetic Foot Ulcer Infection [CODIFI] study) [21] . This study collected comprehensive clinical details, including ulcer classification using both the PEDIS (perfusion, extent, depth, infection, sensation) [22] and the Wagner systems, and wound culture results. After gaining additional funding we obtained consent from participants to enrol them in a prospective observational study to assess the 12-month clinical outcomes of people with a clinically infected diabetic foot ulcer and to explore prognostic factors related to the incidence of wound healing.
Methods

Study design and participants
The CODIFI study enrolled 400 participants between November 2011 and May 2013. Participants were recruited from community podiatry-led and multi-disciplinary diabetic foot ulcer clinics. Eligibility criteria were: diagnosis of diabetes mellitus; foot ulcer suspected of being infected based on clinical signs and symptoms using Infectious Diseases Society of America/International Working Group on the Diabetic Foot [16, 20] criteria and clinical judgement; plan to treat with antibiotics for their infected ulcer; and age ≥ 18 years with written consent provided.
Mid-way through recruitment, we obtained ethics approval for an amendment (November 2012) to enable us to conduct a case note review at 12 months after CODIFI study enrolment. This allowed us to obtain consent prospectively from all subsequently enrolled participants for the 12-month case note review and retrospectively from those previously enrolled in CODIFI who were still alive (by telephone using an ethically approved verbal consent script). We also obtained ethics approval to perform the case note review for enrolled participants who had since died.
Assessments/case note review
At enrolment for the CODIFI study [21] we recorded the following data: baseline demographics; diabetes history; clinical ulcer details (wound duration and site, aetiology, PEDIS and Wagner classification); type, if any, of antibiotic or antimicrobial treatment; and culture results from swab and tissue samples taken from the ulcer.
For the 12-month outcome assessment, research nurses or podiatrists at each participating centre conducted a detailed case note review seeking information on participant status and outcomes relating to the index ulcer, including: whether or not it healed, and if so, the date of healing; index ulcer recurrence; ipsilateral lower limb revascularization procedures; ipsilateral lower extremity amputation; or death in the 12 months following enrolment.
Statistical analysis
Sample size
We expected to obtain consent from at least 200 participants. Assuming a diabetic foot ulcer healing rate of 50%, this would provide an estimate of healing with a precision (half width of the 95% CI) of AE 6.9%. It would also allow us to include a maximum of 10 parameter estimates in an exploratory prognostic model of time to healing [23] .
Population
Analyses were conducted on the follow-up population, which consisted of the sample of all registered and consented CODIFI participants for whom a subsequent case note review was completed. To explore the generalizability of our results, baseline characteristics of all CODIFI participants included vs not included in the follow-up population were compared, with differences explored using the chi-squared and t-test as appropriate.
12-month outcomes
We summarized the outcome of study participants by ulcerrelated events (wound healing, wound recurrence, lower
What's new?
• This is the first prospective study to estimate the incidence of healing and prognostic factors associated with healing in people with a clinically infected diabetic foot ulcer, and specifically in the presence of competing risks of amputation and death.
• Outcomes for people with a clinically infected diabetic foot ulcer are poorer than previously thought; in the first year after presentation with an infected ulcer, 15.1% of our participants had died and 17.4% underwent at least partial lower extremity amputation.
• Healing incidence within 1 year was 44.5% (95% CI 38.9 to 50.1). Three key factors served as the best independent predictors of healing: PEDIS (perfusion, extent, depth, infection, sensation) perfusion grade; the absence of multiple foot ulcers; and shorter ulcer duration. extremity amputation, limb revascularization, and death) as well as the time to the event. Using competing risk analysis (with cumulative incidence functions) we estimated the cumulative incidence of healing at 6 and 12 months. Because either amputation or death would preclude further observation of healing of the index ulcer, for unhealed ulcers we considered death and amputation to be competing risks; thus, we provided healing estimates (with 95% CIs) and cumulative incidence curves of the time to healing, in the presence of competing risks. We censored participants who were alive and without lower extremity amputation or healing of their index ulcer at 12 months post-baseline or the date of their case note review, if this took place before the 12-month follow-up.
Prognostic factors relating to healing
To explore the relationship of baseline factors with cumulative incidence (rate) of healing, we used a proportional subdistribution hazards model [24] for competing risks data. Using exploratory univariable analyses (single explanatory variable), we first tested the association between each prespecified baseline prognostic factor (Table 1 ) separately with incidence of healing. Then, we explored associations between prognostic factors found to be significantly associated with healing using the chi-squared test. We then entered all prespecified factors in a preliminary multivariable (multiple explanatory variables) analysis to examine their independent effects on healing. Lastly, we entered factors that achieved statistical significance at the 10% level into a final multivariable model. For all analyses, we present hazard ratios (HRs) with 95% CIs and P values for prognostic factors we found significantly associated with healing at the 5% level.
Missing data
We assumed that missing data for participants in the followup population (e.g. date of healing, baseline covariates) were missing at random and imputed these values using multiple imputation [25] . Characteristics of participants with and without missing data were compared to explore the pattern of missing data. We performed separate imputation analyses according to the participants' healed status with an imputation model that included all factors considered in the prognostic model, centre, and other outcomes of interest (recurrence, revascularization, amputation and death). We made a total of 10 imputations using the Markov chain Monte Carlo method [26] , and combined results using Rubin's rules [27] .
Results
Consent and participant characteristics
We were able to include a total of 299 participants for the 12-month follow-up analyses in this study. Of these, investigators obtained consent from 250 participants (155 written and 95 by telephone), and for 49 participants who had died but had clinical data available. Figure 1 summarizes the participant flow for this study. The main reason for exclusion was no response to our request for consent (55/400 participants, 14%). As shown in Table 2 , baseline characteristics were largely similar for those included and excluded; however, participants included in the follow-up population were slightly older (mean age 64 vs 59 years; P=0.001), had more recurrent ulcers (30.4% vs 18.8%; P=0.0217), and had more serious infections (65.2% vs 53.5% grade 3 or 4 infection; P=0.0352).
Missing data
There were minimal missing data for participants included in the follow-up population. Date of healing was missing for 12 participants; 4% of all participants and 8.8% of healed participants. There was no clear evidence, however, of a pattern of missing data when comparing participants' baseline characteristics. There were also missing data for the baseline covariates diabetes duration, extent of ulcer, ulcer type and recurrent ulcer for two participants (0.7%), ulcer duration for four participants (1.3%), antimicrobial dressing and HbA 1c for five participants (1.7%) and previous antibiotic regimen for 15 participants (5%). Given the low level of missing data and the use of multiple imputation based on all factors considered in the prognostic model to mitigate against bias, missing data in the long-term follow-up population are unlikely to have biased the statistical analysis. Table 3 summarizes the 12-month clinical outcomes, based on whether or not the index ulcer healed. Healing of the index ulcer at 12 months occurred in 136 participants (45.5%). Among these, ulcer recurrence was reported within the 12 months of follow-up in 13 participants (9.6%). A substantial minority of participants underwent a surgical procedure of the affected lower extremity, with 52 (17.4%) having an amputation of some part of the foot and 18 (6.0%) undergoing revascularization surgery, 10 (3.3%) of whom underwent both revascularization surgery and amputation. Furthermore, 45 participants (15.1%) had died within the 12 month follow-up period.
12-month clinical outcomes
Time to healing and other clinical outcomes
For participants whose index ulcer healed, the median (range) time to healing was 4.5 (0.5-12.9) months (n=136, missing n=12). Adverse events generally occurred relatively early in the clinical course of treatment. For those with a recurrence of the index ulcer, the median (range) time of recurrence was 1.7 (0.3-10.7) months post-healing. For those who underwent revascularization surgery, the median (range) time to surgery was 3.0 (0.1-9.5) months. For those who underwent a lower extremity amputation, the median (range) time to amputation was 2.0 (0.0-10.6) months. Finally, for those who died during the 12-month follow-up, the median (range) time to death was 5.6 (0.6-11.5) months.
The estimated incidence of healing, accounting for competing events of amputation or death, was 27.5% (95% CI 22.4, 32.5) at 6 months and 44.5% (95% CI 38.9, 50.1) at 12 months. Figure 2 shows the estimated cumulative incidence curves of the time to healing and the competing risks of death and amputation.
Prognostic factors associated with healing Univariable analyses showed that 11 of the prespecified factors were potentially associated (based on a P value <0.1) with the incidence of healing of the index ulcer. The incidence of healing was higher if there was only one ulcer (rather than multiple) on the index foot, or if coagulasenegative staphylococci were identified from a culture of the ulcer. The incidence of healing was lower if the index ulcer: (i) had a PEDIS perfusion grade of ≥2; (ii) was classified as ischaemic; (iii) had been present for~2 months or longer prior to CODIFI enrolment; (iv) had a Wagner grade of ≥2; (v) had a PEDIS depth grade of ≥2; (vi) had a PEDIS infection grade of ≥3; (vii) was covered with an antimicrobial dressing at baseline; or (viii) had methicillin-resistant Staphylococcus aureus (MRSA) identified from the ulcer culture (Table 4) .
When fitting all potential prognostic factors into a multivariable proportional sub-distribution hazards model (a preliminary analysis), then into a final analysis model, only four remained statistically significantly associated with the incidence of healing (excluding age; Table 4 ). The incidence of healing was higher if: (i) there was only one ulcer on the index foot (HR 1.9, 95% CI 1.18 to 3.06); or (ii) coagulasenegative staphylococci was identified from the ulcer culture (HR 1.53, 95% CI 0.98 to 2.40). The incidence of healing was lower if the index ulcer: (i) had a PEDIS perfusion grade of ≥2; (HR 0.37, 95% CI 0.25 to 0.55) or (ii) had been present for~2 months or longer prior to CODIFI enrolment (HR 0.55, 95% CI 0.39 to 0.77). Table 5 summarizes pairwise associations between factors related to the incidence of healing. Several factors that were statistically significantly associated with healing in the univariable analysis were no longer statistically significant in the multivariable analysis (ulcer type, PEDIS depth, PEDIS infection, Wagner grade, antimicrobial dressing at baseline, and MRSA isolation).
Associations between factors
Pairwise associations between various factors that met statistical significance (P<0.05; cross-tabulations quantifying these associations are presented in Table S1 ) included ulcer type, and PEDIS perfusion, PEDIS depth, PEDIS infection and Wagner grades. Among these, only PEDIS perfusion grade remained statistically significant in the multivariable analysis, with a higher grade associated with ischaemic ulcers, greater depth, more severe infection and higher Wagner grades. Ischaemic ulcers were also associated with having multiple ulcers on the index foot, a longer-duration ulcer, and a lower rate of isolation of coagulase-negative staphylococci from the ulcer culture, all of which were statistically significant in the multivariable analysis. The presence of an antimicrobial dressing on the ulcer at baseline did not remain statistically significant in the multivariable *For two participants amputation occurred after reported healing of the index ulcer due to another non-index ulcer on the index foot, either present at baseline or developed subsequently. For 10 participants amputation occurred prior to healing of the index ulcer with the amputation being on the index foot but of a different site to that of the index ulcer due to another non-index ulcer on the index foot, either present at baseline or developed subsequently. analysis, but was associated with a higher perfusion grade and a longer ulcer duration. Isolation of MRSA from the ulcer culture was associated with ulcer type, and was more frequently reported from cultures of ischaemic ulcers. Interestingly, isolation on ulcer culture of MRSA was inversely associated with isolation of coagulase-negative staphylococci, each being only reported in the absence of the other.
Discussion
In this large, prospective study with 12 months' follow-up, we found that three key factors served as the best independent predictors of healing of an infected diabetic foot ulcer: the PEDIS perfusion grade; the absence of multiple foot ulcers; and a shorter ulcer duration. A lower perfusion grade suggests the presence of peripheral arterial disease, which previous studies have shown to be an important predictor of poor outcomes (i.e. lack of healing and lower extremity amputation) in people with a diabetic foot ulcer [5, [13] [14] [15] . In the present study, among the five PEDIS domains, perfusion (indicating peripheral arterial disease) was shown to be the only independent predictor of healing. Ulcer duration and presence of multiple ulcers have also been reported as significant predictors for non-healing in other studies [28, 29] . The participants in the present study with a clinically suspected diabetic foot ulcer infection had poorer outcomes than reported in previously published studies, which enrolled people with various types of diabetic foot ulcers [5, [13] [14] [15] . We found a 12-month incidence of healing of 44.5%, while Prompers et al. [5] , Ince et al. [13] and Jeffcoate et al. [14] reported healing rates at 12 months of 77% and 68.3%, respectively. In addition, we found that during 12 months of follow-up for their infected diabetic foot ulcer, 17.4% of our participants underwent at least partial lower extremity amputation and 15.1% died, compared with 22% for amputation and 6% deaths in the study by Prompers et al.
[5] and 5.9% for amputation or death (reported as combined) in the study by Ince et al. [13] These differences may have arisen because we specifically recruited people with a suspected infected diabetic foot ulcer, whereas Prompers et al. [5] included only people presenting with a new foot ulcer and excluded those treated at the participating centres for an ulcer on the ipsilateral foot during the previous 12 months and those with a life expectancy of <1 year; compared with our participants, we would expect their population to have had a better prognosis from the outset. Ince et al. [13] recruited participants from a heterogeneous clinic population. They also used conventional survival analyses to estimate healing rates, which neither accounted nor adjusted for the competing events of amputation or death; this probably overestimates the incidence of healing.
A more complex issue is the association we found between culturing coagulase-negative staphylococci and higher HR, hazard ratio. Bold numbers indicate the direction in which the event is more likely to occur (healing or not healing). *The following factors reported in Table 1 were also included in the exploratory univariable and preliminary multivariable analysis, however, no significant associations were detected at the 10% level: diabetes duration; diabetes type: type 2 vs type 1; insulin therapy; HbA 1c ; ulcer extent; PEDIS sensation grade; incident or recurrent ulcer; ulcer location; previous antibiotic therapy; any reported pathogens; overall anaerobes; Gram-positive cocci; Gram-negative bacilli; Enterobacteriaceae; Gram-positive bacilli; MSSA; Streptococcus; Enterococcus excluding vancomycin resistant, Corynebacterium; Pseudomonas. † The reference level refers to the level of the factor used as the reference in the HRs, i.e. participants with ischaemic ulcers compared with the reference neuropathic ulcers have a lower rate of healing with a HR of 0.5 in univariable analysis. ‡ PEDIS infection grades 3 and 4 were combined in the analysis. § The association with age was not supported when age was explored categorically at various 'splits' in the data.
ª 2017 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK incidence of healing. This is a group of relatively avirulent organisms, and the fact that their presence was inversely related to the presence of the more virulent MRSA may explain the association with healing. There were no statistically significant associations between ulcer healing and any other ulcer culture results, including whether or not the microbiology laboratory reported growth of any microorganisms. Unlike other studies, we found no significant association between the incidence of healing and prognostic factors such as glycaemic control [30] , duration of diabetes [5, 13] , ulcer site, sex [15] , wound area or wound depth [28] . Noteworthy is that poor arterial perfusion often leads to 'punched out' ulcers that are likely to be deeper than nonischaemic ulcers [23] . Our analyses suggest that it is the poor perfusion (peripheral arterial disease) rather than the depth of the ulcer that leads to impaired healing.
We also found a higher incidence of ulcer healing among older participants, but this finding was not consistently supported when we explored age categorically at various 'splits' in the data. As there is no apparent biological basis for this finding or support from results of other studies [31] , we think it is likely to be spurious.
To our knowledge, this is the first prospective study of people with infected diabetic foot ulcers to estimate methodically the cumulative incidence of healing, to report the time to healing, and to identify factors associated with the incidence of healing while adjusting for competing risks. Taking these factors into consideration, we found that conventional survival analysis would have overestimated the incidence of healing in the present study by almost 10%.
As this study recruited participants from 25 centres across England, ranging from large teaching hospitals to small primary healthcare centres, these results are likely to be generalizable to outcomes of diabetic foot ulcers across England, and perhaps in other higher-income countries. This is also the first large study of outcomes of diabetic foot ulcers conducted since publication of the 2011 UK National Institute for Health and Care Excellence (NICE) guidelines on management of diabetic foot problems [17] , which have been updated by new guidelines [19] . The poor outcomes we found in the present study may suggest that either the guideline recommendations have not been widely implemented or they are not very effective. The current NICE guidelines [19] recommend placing systems across all care settings designed to prevent and manage diabetic foot problems; however, a recent UK national audit [32] found that the implementation of the NICE guidelines was not universal.
Diagnosing whether or not a diabetic foot ulcer is infected can be difficult, especially in the presence of peripheral neuropathy or limb ischaemia, but authorities generally agree that it should be based on finding signs or symptoms of inflammation, purulence and possibly other 'secondary' clinical findings [16, 18] . Of the participants enrolled in the main CODIFI study [21] , 12% had a swab or tissue sample growing no pathogens isolated, but almost half were receiving antibiotic therapy and two-thirds were using an antimicrobial dressing. Furthermore, deficiencies in specimen collection, transport or processing may have led to false-negative cultures.
The present study has three key limitations. First, our 12-month case note review was an extension to the original 
